Patrick Matthias

Patrick Matthias

Auto-generated profile, based on publicly available information

Patrick Matthias

Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2003 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
YZYu Zhang
Yu Zhang
NLNa Li
Na Li
CCCécile Caron
Cécile Caron
GMGabriele Matthias
Gabriele Matthias
DHDaniel Hess
Daniel Hess
PMPatrick Matthias
Patrick Matthias
Microtubules are cylindrical cytoskeletal structures found in almost all eukaryotic cell types which are involved in a great variety of cellular processes. Reversible acetylation on the ϵ‐amino group of α‐tubulin Lys40 marks stabilized microtubule structures and may contribute to regulating microtubule dynamics. Yet, the enzymes catalysing this acetylation/deacetylation have remained unidentified until recently. Here we report that β‐tubulin interacts with histone deacetylase‐6 (HDAC‐6) in a yeast two‐hybrid assay and in vitro. We find that HDAC‐6 is a micro tubule‐associated protein capable of deacetylating α‐tubulin in vivo and in vitro. HDAC‐69s microtubule binding and deacetylation functions both depend on the hdac domains. Overexpression of HDAC‐6 in mammalian cells leads to tubulin hypoacetylation. In contrast, inhibition of HDAC‐6 function by two independent mechanisms—pharmacological (HDAC inhibitors) or genetic (targeted inactivation of HDAC‐6 in embryonic stem cells)—leads to hyperacetylation of tubulin and microtubules. Taken together, our data provide evidence that HDAC‐6 might act as a dual deacetylase for tubulin and histones, and suggest the possibility that acetylated non‐histone proteins might represent novel targets for pharmacological therapy by HDAC inhibitors.

1 September 2002 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
VGValerie Geoffroy
Valerie Geoffroy
MKMichaela Kneissel
Michaela Kneissel
BFBrigitte Fournier
Brigitte Fournier
ABAlan Boyde
Alan Boyde
PMPatrick Matthias
Patrick Matthias
The runt family transcription factor core-binding factor α1 (Cbfa1) is essential for bone formation during development. Surprisingly, transgenic mice overexpressing Cbfa1 under the control of the 2.3-kb collagen type I promoter developed severe osteopenia that increased progressively with age and presented multiple fractures. Analysis of skeletally mature transgenic mice showed that osteoblast maturation was affected and that specifically in cortical bone, bone resorption as well as bone formation was increased, inducing high bone turnover rates and a decreased degree of mineralization. To understand the origin of the increased bone resorption, we developed bone marrow stromal cell cultures and reciprocal coculture of primary osteoblasts and spleen cells from wild-type or transgenic mice. We showed that transgenic cells of the osteoblastic lineage induced an increased number of tartrate-resistant acid phosphatase-positive multinucleated cells, suggesting that primary osteoblasts as well as bone marrow stromal cells from transgenic mice have stronger osteoclastogenic properties than cells derived from wild-type animals. We investigated the candidate genes whose altered expression could trigger this increase in bone resorption, and we found that the expression of receptor activator of NF-κB ligand (RANKL) and collagenase 3, two factors involved in bone formation-resorption coupling, was markedly increased in transgenic cells. Our data thus suggest that overexpression of Cbfa1 in cells of the osteoblastic lineage does not necessarily induce a substantial increase in bone formation in the adult skeleton but has a positive effect on osteoclast differentiation in vitro and can also dramatically enhance bone resorption in vivo, possibly through increased RANKL expression.

1 March 1993 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
PMP Matthias
P Matthias
DBD Baltimore
D Baltimore
The transcription of immunoglobulin genes is controlled by variable region promoters and by enhancers, both of which are lymphoid specific. Because immunoglobulin genes are subject to an extremely complex regulation, we anticipated that there might be additional control elements for these genes. We therefore sought additional enhancers and demonstrate here that there is indeed another weak transcriptional enhancer just 3' to the mouse alpha constant region. This novel immunoglobulin enhancer is lymphoid specific and at two positions can bind members of the Oct family of transcription factors.

1 August 2001 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
RTRalph Tiedt
Ralph Tiedt
BBBoris A. Bartholdy
Boris A. Bartholdy
GMGabriele Matthias
Gabriele Matthias
JNJohn W. Newell
John W. Newell
PMPatrick Matthias
Patrick Matthias
The transcriptional coactivator OBF‐1, which interacts with Oct‐1 and Oct‐2 and the octamer site DNA, has been shown to be critical for development of a normal immune response and the formation of germinal centers in secondary lymphoid organs. Here we have identified the RING finger protein Siah‐1 as a protein interacting specifically with OBF‐1. This interaction is mediated by the C‐terminal part of Siah‐1 and by residues in the N‐terminus of OBF‐1, partly distinct from the residues required for formation of a complex with the Oct POU domains and the DNA. Interaction between Siah‐1 and OBF‐1 leads to downregulation of OBF‐1 protein level but not mRNA, and to a corresponding reduction in octamer site‐dependent transcription activation. Inhibition of the ubiquitin‐proteasome pathway in B cells leads to elevated levels of OBF‐1 protein. Furthermore, in immunized mice, OBF‐1 protein amounts are dramatically increased in primary activated B cells, without concomitant increase in OBF‐1 mRNA. These data suggest that Siah‐1 is part of a novel regulatory loop controlling the level of OBF‐1 protein in B cells.

1 December 1998 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
PSPatrick Sauter
Patrick Sauter
PMPatrick Matthias
Patrick Matthias
The lymphoid-specific transcriptional coactivator OBF-1 (also known as OCA-B or Bob-1) is recruited to octamer site-containing promoters by interacting with Oct-1 or Oct-2 and thereby enhances the transactivation potential of these two Oct factors. For this interaction the POU domain is sufficient. By contrast, OBF-1 does not interact with the POU domains of other POU proteins, such as Oct-4, Oct-6, or Pit-1, even though these factors bind efficiently to the octamer motif. Here we examined the structural requirements for selective interaction between the POU domain and OBF-1. Previous data have shown that formation of a ternary complex among OBF-1, the POU domain, and the DNA is critically dependent on residues within the octamer site. By methylation interference analysis we identified bases that react differently in the presence of OBF-1 compared to the POU domain alone, and using phosphothioate backbone-modified probes in electrophoretic mobility shift assays, we identified several positions influencing ternary complex formation. We then used Oct-1/Pit-1 POU domain chimeras to analyze the selectivity of the interaction between OBF-1 and the POU domain. This analysis indicated that both the POU specific domain (POUS) and the POU homeodomain (POUH) contribute to complex formation. Amino acids that are different in the Pit-1 and Oct-1 POU domains and are considered to be solvent accessible based on the Oct-1 POU domain/DNA cocrystal structure were replaced with alanine residues and analyzed for their influence on complex formation. Thereby, we identified residues L6 and E7 in the POUS and residues K155 and I159 in the POUH to be critical in vitro and in vivo for selective interaction with OBF-1. Furthermore, in an in vivo assay we could show that OBF-1 is able to functionally recruit two artificially separated halves of the POU domain to the promoter DNA, thereby leading to transactivation. These data allow us to propose a model of the interaction between OBF-1 and the POU domain, whereby OBF-1 acts as a molecular clamp holding together the two moieties of the POU domain and the DNA.

1 January 2000 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
DSDaniel B. Schubart
Daniel B. Schubart
ARAntonius Rolink
Antonius Rolink
KSKarin Schubart
Karin Schubart
PMPatrick Matthias
Patrick Matthias
OBF-1 is a B cell-restricted transcriptional coactivator that is recruited to octamer-containing promoters by interacting with the POU domain of Oct-1 or Oct-2. We have shown earlier that mice lacking OBF-1 were dramatically impaired in their ability to mount humoral immune responses and did not develop germinal centers in the spleen; however, they had a largely normal B cell development in the bone marrow. In this study, we demonstrate that OBF-1-deficient mice also have an early defect in B cell development and show that OBF-1−/− immature B cells are greatly impaired at the transition from the bone marrow to the spleen. In addition, when the OBF-1 mutation is combined to a mutation in the gene encoding Bruton’s tyrosine kinase, a striking phenotype is observed. These double-deficient animals lack peripheral B cells and have virtually no serum Igs, thus closely resembling human X chromosome-linked agammaglobulinemia.